Conmed Stock – Fundamental Analysis
Fundamental Data & Ratios (Balance sheet update: 7/25/2026)
| Balance Sheet | Total Assets | 2,325,749,000.00 | ROE | 44.42 % |
| Balance Sheet | Total Equity | 1,045,984,000.00 | ROA | 2.02 % |
| Cashflow | Capital Expenditures | -19,806,000.00 | P/FCF | 9.28 |
| Cashflow | Free Cash Flow | 150,883,000.00 | – | – |
| Cashflow | Operating Cash Flow | 170,689,000.00 | P/CF | 8.20 |
| Income | Earnings per Share (diluted) | 1.51 | Div. Yield | 1.34 % |
| Income | Net Income | 47,055,000.00 | P/E | 29.76 |
| Income | Shares Outstanding | 31,149,000.00 | P/B | 1.35 |
| Income | Total Revenue | 1,374,724,000.00 | P/S | 1.02 |
Ratios calculated on: 10/14/2026
Company Description
CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company´s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company´s powered instruments product line includes the MPower battery system. The Company´s patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.conmed.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more